Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells

Area of Science:

• Oncology
• Immunology
• Pharmacology

Background:

• Monoclonal antibodies (mAbs) are crucial in tumor therapy.
• Clinical responses to mAb therapy are often suboptimal, with patients exhibiting resistance.
• MAbs employ diverse antitumor mechanisms, frequently requiring immune cell interaction.

Purpose of the Study:

• To classify the mechanisms of action for antitumor mAbs.
• To review the role of immune cell interactions in mAb therapy efficacy.
• To identify strategies for improving mAb and immune cell tumor accumulation and interaction affinity.

Main Methods:

• Literature review and evidence synthesis on mAb mechanisms.
• Analysis of factors limiting mAb and immune cell tumor infiltration.
• Examination of mAb-immune cell interaction dynamics and affinity.

Main Results:

• MAbs exert antitumor effects via multiple mechanisms, some requiring immune cell engagement.
• Suboptimal responses are linked to insufficient mAb or immune cell tumor accumulation.
• Low-affinity interactions between mAbs and immune cells can impair therapeutic outcomes.

Conclusions:

• Enhancing mAb and immune cell tumor accumulation is critical for efficacy.
• Improving the affinity of mAb-immune cell interactions can boost antitumor responses.
• Future research should focus on optimizing these factors for improved mAb cancer therapy.